Table 1.
Controls | PD-DA | PD+DA | DBS-DA | DBS+DA | t statistic χ 2 or F-statistic | p-value | |
---|---|---|---|---|---|---|---|
Participants(no.) | 18 | 14 | 20 | 11 | 16 | ||
Gender (male) | 15 | 11 | 19 | 10 | 11 | χ 2=5.1 | 0.27 |
Age (yrs) | 58.9±12.8 | 67.2±7.5 | 64.3±5.2 | 57.0±7.0 | 59.1±11.6 | F=3.0 | 0.023 |
Age PD of diagnosis | 61.1±2.2 | 53.2±1.8 | 42.5±2.3 | 43.7±2.2 | F=15.9 | <0.001* | |
PD Disease duration (yrs) | 6.2±3.8 | 11.1±7.0 | 14.4±5.0 | 15.6±6.0 | F=7.3 | <0.001* | |
DBS (yrs) | 3.4±3.3 | 3.6±2.2 | t=0.2 | 0.8 | |||
Education (yrs) | 13.6±3.2 | 14.8±3.1 | 14.5±2.5 | 13.9±2.8 | 13.7±2.8 | F=0.4 | 0.75 |
LEU dose(mg/day) | 511±321 | 854.2±356 | 739.2±409 | 771.4±337 | F=2.6 | 0.058 | |
DA dose (LEU) | 216.0±109 | 204.9±97.1 | t=0.3 | 0.7 | |||
UPDRS on | 16.0±2.3 | 19.4±11.6 | 16.5±4.4 | 17.6±4.4 | F=0.5 | 0.6 | |
DA duration (yrs) |